Benzimidazole derivative and preparation method and application as medicine thereof

A drug, benzo technology, applied in the field of pharmacology, can solve problems such as single action

Active Publication Date: 2019-03-12
GUANGDONG PHARMA UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In terms of drug treatment of metabolic syndrome, the hypoglycemic drugs or lipid-lowering drugs currently used in clinical practice have a single effect, and none of them have an ideal effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Benzimidazole derivative and preparation method and application as medicine thereof
  • Benzimidazole derivative and preparation method and application as medicine thereof
  • Benzimidazole derivative and preparation method and application as medicine thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] 2-Methyl-2-(2-methyl-4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)propanoic acid (I-1)

[0068]

[0069] first step

[0070] Methyl 2-(4-formyl-2-methylphenoxy)-2-methylpropanoate (2a)

[0071] Dissolve 3-methyl-4-hydroxybenzaldehyde 1a (1.0g, 7.35mmol) and methyl 2-bromoisobutyrate (4.0g, 22.1mmol) in acetonitrile (20mL), add potassium carbonate (3.0g, 22.1mmol), reacted at 50°C for 12h, after TLC detected that the reaction was complete, added water to dissolve the solid mixture in the reaction, extracted with ethyl acetate (30mL×4), combined the organic phases with water (20mL×1), 1NHCl (20mL×1 ), washed with saturated NaCl solution (20mL×2), dried, concentrated, and the resulting product was directly used in the next reaction without purification.

[0072] second step

[0073] Methyl 2-methyl-2-(2-methyl-4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)propanoate (3a)

[0074] Dissolve 2a (0.5g, 2.12mmol) and 3,4-diaminotoluene (0.29g, 2.12mmol) in DMF (15mL) with...

Embodiment 2

[0080] 2-Methyl-2-(2-methyl-4-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)phenoxy)propanoic acid (I-2)

[0081]

[0082] Referring to the preparation method of I-1, 1.5 g of white solid was obtained with a yield of 43%.

[0083] 1 H NMR (300MHz, D 2 O) δ: 10.67-10.44(m, 2H), 10.26(s, 1H), 10.17(d, J=8.5Hz, 1H), 10.00(d, J=8.5Hz, 1H), 9.09(d, J= 8.7Hz, 1H), 5.37(s, 1H), 4.47(s, 3H), 3.84(s, 6H). 13 C NMR (75MHz, DMSO-d 6 )δ: 174.87, 158.57, 151.79, 135.46, 132.90, 131.31, 129.53, 128.01, 126.47, 126.05, 125.62, 122.27, 115.79, 115.35, 111.67, 79.69, 25.60, 137.87 m.z [ES-MS] m.z - .Anal.calcd.For C 19 h 17 f 3 N 2 o 3 : C, 60.32; H, 4.53; N, 7.40; Found: C, 60.15; H, 4.38; N, 7.52.

Embodiment 3

[0085] 2-(2-fluoro-4-(6-methyl-1H-benzo[d]imidazol-2-yl)phenoxy)-2-methylpropanoic acid (I-3)

[0086]

[0087] Referring to the preparation method of I-1, 0.29 g of white solid was obtained with a yield of 49%.

[0088] 1 H NMR (300MHz, D 2 O) δ: 10.74-10.57(m, 1H), 10.44(d, J=8.7Hz, 1H), 9.89(d, J=8.4Hz, 1H), 9.80(s, 1H), 9.56(d, J= 8.4Hz, 1H), 9.38(t, J=8.6Hz, 1H), 5.37(s, 1H), 4.69(s, 3H), 3.85(s, 6H). 13 C NMR (75MHz, DMSO-d 6 )δ: 174.23, 147.62, 147.38, 136.27, 132.54, 130.41, 127.75, 125.41, 119.85, 116.52, 113.90, 113.69, 81.16, 25.43, 21.64. ESI-MS m / z: 327.1 [M-H] - .Anal.calcd.For C 18 h 17 FN 2 o 3 : C, 65.85; H, 5.22; N, 8.53; Found: C, 65.67; H, 5.35; N, 8.58.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a novel benzimidazole PPAR alpha/gamma/delta panto-agonist as shown in the general formula (I) and a preparation method thereof and application of a medicine compound containing the derivative in preparing a medicine for preventing or/and treating abnormal glucose metabolism or/and abnormal lipids metabolism disease. The PPAR alpha/gamma/delta panto-agonist has excellent in-vivo hypoglycemic activity and blood fat adjusting action, can be applied for preparing medicines for preventing or/and treating metabolic syndrome related diseases of diabetes, obesity, hyperlipidemia, atherosclerosis, fatty liver and the like, and has wide application prospects.

Description

technical field [0001] The present invention relates to the field of pharmacy related to glucose and lipid metabolic diseases, in particular to a new benzimidazole derivative, its preparation method and a pharmaceutical composition containing the derivative as a drug for the preparation of glucose and lipid metabolic diseases Applications. The derivative structures involved in the present invention are unique and novel in this field. Background technique [0002] Metabolic syndrome is a common disease characterized by abnormal glucose and lipid metabolism, accompanied by elevated low-density lipoprotein and low high-density lipoprotein cholesterol. The common symptoms are obesity, diabetes, hyperlipidemia, atherosclerosis Cirrhosis and fatty liver, etc. Among them, diabetic patients often have hyperlipidemia, cardiovascular disease, diabetic nephropathy, diabetic neuropathy and other diseases. [0003] According to the World Health Organization, more than 220 million peopl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D235/18A61K31/4184A61P3/10A61P3/04A61P3/06A61P9/10A61P3/00A61P1/16
CPCA61P1/16A61P3/00A61P3/04A61P3/06A61P3/10A61P9/10C07D235/18
Inventor 李政张陆勇刘柔佳
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap